1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts

Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts

  • December 2016
  • ID: 4794599
In this report:
Physicians look to stratify their patients in order to identify the most appropriate treatment, and the addition of companion diagnostic tests is seen as an extra tool in the existing prognostic process.
In practice, this involves measuring the expression or presence of a specific biomarker that is linked to a disease condition or therapy in order to ascertain how a patient will respond to a particular treatment.

Summary

Table of Contents

Companion Diagnostic Tests In Oncology - APAC Analysis and Market Forecasts

Brief

Companion diagnostics is synonymous with personalized, stratified, and precision medicine, and heralds a additional era of treatment in which a patients' treatment will become increasingly individualized. A companion diagnostic test is defined as an in vitro diagnostic device or imaging tool whose use allows the safe application of a therapy. In practice, this involves measuring the expression or presence of a particular biomarker that is linked to a disease condition or therapy in order to ascertain how a patient will respond to a unique treatment. A relatively narrow range of core technologies is used for companion diagnostic tests, based around the detection of nucleic acids or proteins.

The increased demand for companion diagnostic tests is a result of the increased demand from physicians who want to be superior informed of the therapy options for their patients, from regulatory authorities who are seeking the development of safer and more effective drugs, and from healthcare authorities who are looking to control the growing costs of therapies while being able to superior identify the most suitable patients for treatment. Physicians look to stratify their patients in order to distinguish the most appropriate treatment, and the addition of companion diagnostic tests is seen as an extra tool in the existing prognostic process.

This business report focuses on the companion diagnostic testing markets in Japan (JP), China (CN) and India (IN), to recognize unmet needs in the APAC market, physician attitudes toward current companion diagnostic testing, and the future of companion diagnostic testing in the face of quick technological advancement. The four main cancers examined in this industry report are breast cancer, colorectal cancer, non-small cell lung cancer, and melanoma.

*This is an on-demand report and will be delivered within 4 working days of the purchase.

Key Findings

Key questions & answers

- What is the current and future companion diagnostics market outlook in the developed and emerging markets? What forecasts are affecting the industry?

- Which are the key, high growth markets that companion diagnostic test manufacturers should expand into? Which markets are increasing the quickest, and what are the top-selling products in each segment?

- What are the unmet needs with the current generation of companion diagnostic tests? How will emerging technologies fulfill these unmet needs?

- What clinical factors and technical specifications influence a physician to use one type of test over another? What is physician perception and market outlook for companion diagnostics?

- What are the challenges and complications that have hindered widespread adoption?

- With developing the next-generation of companion diagnostic tests, what aspects of the technology are manufacturers focused on optimizing? How will additional entrants impact the companion diagnostic market?

Overview

- Overview of new top industry events and analysis of their market impact.

- Annualized global market revenue by type of test, procedure trends, and market outlooks by segment and by region through 2023

- Key topics covered include tactical competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region included in the market research, and implications of the emerging technologies in the sector.

- Pipeline analysis: Comprehensive data split across distinct stages of development, containing a discussion of emerging trends and tests in development.

- Analysis of the current and future market competition in the companion diagnostics market. Insightful review of the main industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Great reasons to purchase

- "What Physicians Think" quotes provide a singular insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is vitally for all tactical decision makers in every organization permitting them to act on high quality information.

Please note: this report requires certain updates. We have all the information available but require 4 working days business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2018

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2018SummaryTyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) pipeline Target constitutes ...

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2018

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2018SummaryLymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) pipeline Target constitutes close ...

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2018

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2018SummaryTelomerase Reverse Transcriptase (HEST2 ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on